Testing effectiveness (Phase 2)Active Not RecruitingNCT06706388
What this trial is testing
Personalized Antisense Oligonucleotide Therapy for a Single Participant with ATN1 Gene Mutation
Who this might be right for
Dentatorubral-Pallidoluysian Atrophy
n-Lorem Foundation 1